Cognition and focus
Cognition, memory, and focus
Goal tierC
Direct human evidence
Limited1 direct studies
Positive
1
No clear difference
0
Mixed
0
Negative
0
Research intake observed
Research intake was not verifiable in the available source text.
Public-ready7/6/2026
Bacopa
Papers analyzed
72
Cognition, memory, and focusStress Response and Sleep ChangesExercise performance and recovery
Main benefit evidence
Review human evidence by goal.
Check this goal in more detail
Stress and mood
Stress Response and Sleep Changes
Goal tierNot rated yet
No direct evidence for general supplement use is confirmed under the current standard.
Check this goal in more detailExercise performance and recovery
Exercise performance and recovery
Goal tierNot rated yet
The currently linked research coverage is not broad enough to characterize this goal yet.
Check this goal in more detailSide effects and combination findings in studies
Findings from studies of this ingredient alone are separated from findings involving another supplement or medication.
Caution signals
3
Side effects + combos + curated rules
Key precautions
No curated contraindication rule is available yet, but literature caution signals are shown below.
These are signals reported in studies. They do not predict what will happen to an individual.
Findings to review with care
Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.
Side effects reported when this ingredient was used alone
Symptoms or adverse events reported in studies of this ingredient without another active ingredient.
mild side-effects1 papers
Only 2.3% of participants reported mild side-effects, indicating good tolerability.Human studies · Systematic reviewGastrointestinal tract side-effects1 papers
Bacopa monnieri administration was associated with gastrointestinal side effects including increased stool frequency, abdominal cramps, and nausea.Human studies · Randomized controlled trialAdverse events (stomach upset)1 papers
Bacopa monnieri was well tolerated with few adverse events, primarily mild stomach upset, occurring in 9 participants compared to 10 in the placebo group.Human studies · Randomized controlled trialBacopa
arrow_backBack to list